GPA
FBT icon

Guidance Point Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Guidance Point Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-310
Closed -$51K – 190
2021
Q3 		$51K Buy
+310
New +$53K 0.02% 148

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Guidance Point Advisors's FBT Position: Q4 2021 in Review

Guidance Point Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2021, closing a stake of 310 shares — an estimated $51K sold.

Guidance Point Advisors first reported a position in FBT in Q3 2021 and held it in 1 quarter. The position peaked at $51K in Q3 2021. 247 funds tracked by Wall St. Rank hold FBT as of Q4 2021.

  • Guidance Point Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2021 after selling out during the quarter.
  • Guidance Point Advisors sold 310 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2021, an estimated $51K.
  • Guidance Point Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2021 and held it in 1 quarter.
  • Guidance Point Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $51K in Q3 2021.
  • 247 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.